Eli Lilly will face jury trials in August for claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta.
Lilly's attempts to have the lawsuits thrown out were unsucessful, so the drugmaker must now face jurors who will decide if Lilly "designed Cymbalta studies to under-report the risk of discontinuation symptoms,” according to Bloomberg.
Lilly is facing more than 5,000 claims saying the drugmaker downplayed blockbuster Cymbalta’s withdrawal side effects, which allegedly include electrical-shock sensations described as “brain zaps” as well as nausea, vomiting and insomnia.
Read the Bloomberg article